-transparent.png){kind=logo}
The clinical course, changes in liver function tests and the behaviour of viral markers over the course of time have been examined in 45 patients with acute hepatitis B and 14 patients with acute hepatitis caused by B and D viruses coinfection. There were no significant differences either in the clinical course or in the liver function tests, in the two groups. The changes in serum viral markers were as follows: HBV-DNA was the first marker to disappear; this was closely followed by HBeAg, and HBsAg was the last marker to become negative, during convalescence. This pattern was not altered by Delta coinfection. When we quantified serum HBV-DNA in both groups of patients, we found that Delta virus infection led to parital inhibition of HBV replication, so that serum HBV-DNA levels were significantly lower in those patients with acute hepatitis B who were simultaneously infected with Delta virus.
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
January 1987,
Hepatology (Baltimore, Md.),
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
March 1991,
Hepatology (Baltimore, Md.),
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
February 2013,
Clinical liver disease,
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
June 1990,
Hepatology (Baltimore, Md.),
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
November 2014,
Cold Spring Harbor perspectives in medicine,
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
May 2024,
Innere Medizin (Heidelberg, Germany),
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
May 1992,
Gastroenterology,
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
January 1998,
Antiviral therapy,
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
October 2014,
World journal of gastroenterology,
A L Morante, and
F de la Cruz, and
C R de Lope, and
S Echevarria, and
G M Rodriguez, and
F Pons-Romero
August 2023,
Antiviral therapy,
